Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-017-3466-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial

Oncotarget
Oncology
2016English

Safety of UFT/LV and S-1 as Adjuvant Therapy for Stage III Colon Cancer in Phase III Trial: ACTS-CC Trial

British Journal of Cancer
Cancer ResearchOncology
2012English

Lapatinib-Capecitabine Versus Capecitabine Alone as Radiosensitizers in RAS Wild-Type Resectable Rectal Cancer, an Adaptive Randomized Phase II Trial (LaRRC Trial): Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2016English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

P2.04-25 Randomized Clinical Trial Comparing Immunotherapy Plus SABR (I-Sabr) Versus SABR Alone for Early Stage NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Age-Dependent Response to Multimodal Therapy for Stage II-III Rectal Cancer

Oncotarget
Oncology
2019English

Randomized Phase II Trial Designs With Biomarkers

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer

Annals of Coloproctology
Gastroenterology
2019English

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III a/B Unresectable Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy